Escher T, Dandawate P, Sayed A, Hagan C, Anant S, Lewis Wambi J. Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer. Cancers (Basel). 2021;13: pubmed publisher

Kaushik S, Sanawar R, Lekshmi A, Chandrasekhar L, Nair M, Bhatnagar S, et al. ER alpha selective chromone, isoxazolylchromones, induces ROS-mediated cell death without autophagy. Chem Biol Drug Des. 2019;: pubmed publisher

Sanawar R, Mohan Dan V, Santhoshkumar T, Kumar R, Pillai M. Estrogen receptor-α regulation of microRNA-590 targets FAM171A1-a modifier of breast cancer invasiveness. Oncogenesis. 2019;8:5 pubmed publisher

Watanabe K, Yamamoto S, Sakaguti S, Isayama K, Oka M, Nagano H, et al. A novel somatic mutation of SIN3A detected in breast cancer by whole-exome sequencing enhances cell proliferation through ERα expression. Sci Rep. 2018;8:16000 pubmed publisher

Chan K, Siu M, Jiang Y, Wang J, Leung T, Ngan H. Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancer. Cancer Cell Int. 2018;18:65 pubmed publisher

Li S, Dang Y, Zhou X, Huang B, Huang X, Zhang Z, et al. Formononetin promotes angiogenesis through the estrogen receptor alpha-enhanced ROCK pathway. Sci Rep. 2015;5:16815 pubmed publisher

Dong P, Jiang L, Liu J, Wu Z, Guo S, Zhang Z, et al. Induction of paclitaxel resistance by ER? mediated prohibitin mitochondrial-nuclear shuttling. PLoS ONE. 2013;8:e83519 pubmed publisher

He Z, Zhang S, Meng Q, Li S, Zhu H, Raquil M, et al. Shp2 controls female body weight and energy balance by integrating leptin and estrogen signals. Mol Cell Biol. 2012;32:1867-78 pubmed publisher

Yu J, Akishita M, Eto M, Ogawa S, Son B, Kato S, et al. Androgen receptor-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells: role of phosphatidylinositol 3-kinase/akt pathway. Endocrinology. 2010;151:1822-8 pubmed publisher